Built to solve a specific problem in GLP-1 care.
Adherix Health is a healthcare technology company that builds behavior-driven adherence systems for GLP-1 treatment programs. We help clinics detect patient disengagement early, trigger automated interventions, and retain more patients through the full treatment journey.
Most GLP-1 programs lose patients in silence.
Clinics invest heavily to get patients started — intake workflows, coordinators, sign-up tracking. Then treatment begins and visibility disappears. Nobody is watching the signals that predict churn: replies slowing down, doses spacing out, engagement fading.
In GLP-1 programs, that gap has a number attached to it. Patients who drift in the first 90 days rarely come back. Adherix closes that gap with an SMS-first engagement layer that runs automatically — detecting disengagement early and correcting it before the care team ever has to get involved.
The platform uses phase-based progression and trigger-based logic to move each patient from initiation through onboarding, activation, momentum, and plateau. When a patient goes silent, Adherix detects the pattern and responds. Everything is tracked. Everything is measurable.
Adherix Health
Adherix Health is a healthcare technology company founded in 2024 by Sean Johnson, a healthcare operator with a decade of enterprise growth experience across health tech and digital transformation — including roles at Phreesia and Unlock Health.
We are headquartered in the United States and focused exclusively on the metabolic care market. Our platform is designed for GLP-1 clinics that need patient retention infrastructure without adding to their team's workload.
To reach us: hello@adherixhealth.com — or book a demo at demos@adherixhealth.com.
See it running on a real patient panel.
30-minute walkthrough. No slides. Real platform, realistic data.